GLP-1 weight-loss drugs are changing how people date and connect. In a nationally representative survey of 2,000 single U.S.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

MariTide, a groundbreaking weight loss medication, shows 16% weight reduction in trials. Learn about this promising monthly ...

If you’ve been taking Ozempic or Wegovy (both of which contain the active ingredient semaglutide), you might wonder, How long ...

Experts are warning people using weight-loss jabs could be invalidating travel insurance if they fail to declare the ...

Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, ...

Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with ...

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...

Relying on Ozempic or Mounjaro to keep your weight in check can result in other issues, such as muscle wastage instead of fat ...

In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...